Joris W.P. Vernooij

Internet based vascular risk factor management for patients with clinically manifest vascular disease: randomised controlled trial

Joris W.P. Vernooij, H. A. H. Kaasjager, Yolanda van der Graaf et al. · BMJ · 2012 · 77 citations · Full text

Medicine, Cardiology, Health Informatics +17

Hypertensive target organ damage and the risk for vascular events and all-cause mortality in patients with vascular disease

Joris W.P. Vernooij, Yolanda van der Graaf, Hendrik M. Nathoe et al. · Journal of Hypertension · 2013 · 38 citations

Medicine, Cardiology, Nephrology +17

Cost-effectiveness of a nurse-led internet-based vascular risk factor management programme: economic evaluation alongside a randomised controlled clinical trial

Jacoba P. Greving, H. A. H. Kaasjager, Joris W.P. Vernooij et al. · BMJ Open · 2015 · 27 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Increased Visceral Adipose Tissue Is Associated With Increased Resting Heart Rate in Patients With Manifest Vascular Disease

Remy H.H. Bemelmans, Yolanda van der Graaf, Hendrik M. Nathoe et al. · Obesity · 2011 · 27 citations · Full text

Life Sciences, Endocrinology, Physiology +17

The risk of resting heart rate on vascular events and mortality in vascular patients

Remy H.H. Bemelmans, Yolanda van der Graaf, Hendrik M. Nathoe et al. · International Journal of Cardiology · 2013 · 26 citations

Medicine, Cardiology, Internal Medicine +15